Skip to main content

Table 1 Specifications of the included studies in this meta-analysis

From: Evaluation of the association between KIR polymorphisms and systemic sclerosis: a meta-analysis

Author (Ref)Published YearCountry/RaceDetection TechniqueSSc PatientsControlsKIR Polymorphisms
NN
T. Momot [1]2004Germany/CaucasianPCR1021002DL1, 2DL2, 2DL3, 2DS1, 2DS2, 2DS3, 2DS4, 3DS1, 3DL1
P. H. Salim [2]2013Brazilian/CaucasianPCR1151152DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1,2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1
JD. Tozkır [3]2016Turkey/EdirnePCR-SSP25402DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DL5A, 2DL5B, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1, 3DP1
M. Mahmoudi [4]2017Iranian/CaucasianPCR-SSP2794512DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DL5A, 2DL5B, 3DL1, 3DL2, 3DL3, 2DS1, 2DS2, 2DS3, 2DS4, 2DS4 (full), 2DS4 (var), 2DS5, 3DS1, 2DP1, 3DP1, 3DP1 (full), 3DP1 (var)
AC. Machado-Sulbaran [5]2019MexicoPCR-SSP50902DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1, 3DP1